Related Experiment Video
Updated: Apr 6, 2026
08:26
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
2.1K
Short-term and Long-term Outcomes Regarding Laparoscopic Versus Open Surgery for Low Rectal Cancer: A Systematic
Jin-bo Jiang1, Kun Jiang, Jing-jing Wang
1Departments of *General Surgery ‡Interventional Radiology, Qilu Hospital †School of Medicine, Shandong University, Jinan, Shandong Province, China.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|August 5, 2015
Summary
Laparoscopic surgery is a safe and feasible option for treating low rectal cancer. This minimally invasive approach offers benefits such as reduced blood loss and shorter hospital stays compared to traditional methods.
Area of Science:
- Colorectal Surgery
- Minimally Invasive Surgery
- Oncology
Background:
- Low rectal cancer presents unique surgical challenges.
- Minimally invasive techniques are increasingly explored for complex oncological procedures.
Purpose of the Study:
- To evaluate the feasibility and safety of laparoscopic surgery for low rectal cancer.
- To compare laparoscopic versus open surgical approaches in this patient population.
Main Methods:
- Systematic literature search across major biomedical databases (PubMed, Embase, etc.).
- Meta-analysis of twelve eligible studies involving 2973 patients.
- Statistical evaluation of heterogeneity and test performance using Review Manager 5.2.
Main Results:
- Laparoscopic surgery demonstrated significantly less blood loss, fewer transfusions, and shorter recovery times.
- Patients undergoing laparoscopic surgery experienced reduced overall complications and wound infection rates.
- Key oncological outcomes including resection margins, recurrence rates, and survival were comparable between laparoscopic and open surgery.
Conclusions:
- Laparoscopic surgery is a safe and feasible technique for the treatment of low rectal cancer.
- The benefits include improved short-term recovery and reduced morbidity without compromising oncological safety.
